141 related articles for article (PubMed ID: 31818650)
21. On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques.
Kaulich TW; Zurheide J; Haug T; Budach W; Nüsslin F; Bamberg M
Strahlenther Onkol; 2004 Jun; 180(6):358-64. PubMed ID: 15175870
[TBL] [Abstract][Full Text] [Related]
22. Varian HDR surface applicators - commissioning and clinical implementation.
Iftimia I; McKee AB; Halvorsen PH
J Appl Clin Med Phys; 2016 Mar; 17(2):231-248. PubMed ID: 27074486
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of a 2D diode array in "magic phantom" for use in high dose rate brachytherapy pretreatment quality assurance.
Espinoza A; Petasecca M; Fuduli I; Howie A; Bucci J; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2015 Feb; 42(2):663-673. PubMed ID: 28102606
[TBL] [Abstract][Full Text] [Related]
24. A patch source model for treatment planning of ruthenium ophthalmic applicators.
Astrahan MA
Med Phys; 2003 Jun; 30(6):1219-28. PubMed ID: 12852546
[TBL] [Abstract][Full Text] [Related]
25. Design and evaluation of a HDR skin applicator with flattening filter.
Granero D; Pérez-Calatayud J; Gimeno J; Ballester F; Casal E; Crispín V; van der Laarse R
Med Phys; 2008 Feb; 35(2):495-503. PubMed ID: 18383670
[TBL] [Abstract][Full Text] [Related]
26. Calculation of beta-ray dose distributions from ophthalmic applicators and comparison with measurements in a model eye.
Cross WG; Hokkanen J; Järvinen H; Mourtada F; Sipilä P; Soares CG; Vynckier S
Med Phys; 2001 Jul; 28(7):1385-96. PubMed ID: 11488569
[TBL] [Abstract][Full Text] [Related]
27. [Optimizing target volume assessment in irradiation of intraocular melanomas with ruthenium applicators].
Poier E; Langmann G; Leitner H; Vidic B
Fortschr Ophthalmol; 1991; 88(2):158-60. PubMed ID: 1855736
[TBL] [Abstract][Full Text] [Related]
28. Recommendations on detectors and quality control procedures for brachytherapy beta sources.
Kollaard RP; Dries WJ; van Kleffens HJ; Aalbers TH; van der Marel H; Marijnissen HP; Piessens M; Schaart DR; de Vroome H
Radiother Oncol; 2006 Feb; 78(2):223-9. PubMed ID: 16457901
[TBL] [Abstract][Full Text] [Related]
29. Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV).
Tedgren AC; Hedman A; Grindborg JE; Carlsson GA
Med Phys; 2011 Oct; 38(10):5539-50. PubMed ID: 21992372
[TBL] [Abstract][Full Text] [Related]
30. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
[TBL] [Abstract][Full Text] [Related]
31. Technique for routine output verification of Leipzig applicators with a well chamber.
Pérez-Calatayud J; Granero D; Ballester F; Crispín V; Van der Laarse R
Med Phys; 2006 Jan; 33(1):16-20. PubMed ID: 16485404
[TBL] [Abstract][Full Text] [Related]
32. Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators.
Moradi F; Ung NM; Khandaker MU; Mahdiraji GA; Saad M; Abdul Malik R; Bustam AZ; Zaili Z; Bradley DA
Phys Med Biol; 2017 Jul; 62(16):6550-6566. PubMed ID: 28708603
[TBL] [Abstract][Full Text] [Related]
33. Absorbed dose measurements of a handheld 50 kVP X-ray source in water with thermoluminescence dosemeters.
Soares C; Drupieski C; Wingert B; Pritchett G; Pagonis V; O'Brien M; Sliski A; Bilski P; Olko P
Radiat Prot Dosimetry; 2006; 120(1-4):78-82. PubMed ID: 16735571
[TBL] [Abstract][Full Text] [Related]
34. Thermoluminescence dosimetry measurements of brachytherapy sources in liquid water.
Tailor R; Tolani N; Ibbott GS
Med Phys; 2008 Sep; 35(9):4063-9. PubMed ID: 18841858
[TBL] [Abstract][Full Text] [Related]
35. Use of Thermoluminescence Dosimetry for QA in High-Dose-Rate Skin Surface Brachytherapy with Custom-Flap Applicator.
Manna F; Pugliese M; Buonanno F; Gherardi F; Iannacone E; La Verde G; Muto P; Arrichiello C
Sensors (Basel); 2023 Mar; 23(7):. PubMed ID: 37050652
[TBL] [Abstract][Full Text] [Related]
36. Rectum dose analysis employing a multi-purpose brachytherapy phantom.
Huh H; Kim W; Loh JJ; Lee S; Kim CY; Lee S; Shin D; Shin D; Cho S; Jang J; Lim S; Cho KH; Kwon S; Kim S
Jpn J Clin Oncol; 2007 May; 37(5):391-8. PubMed ID: 17538010
[TBL] [Abstract][Full Text] [Related]
37. Using LiF:Mg,Cu,P TLDs to estimate the absorbed dose to water in liquid water around an 192Ir brachytherapy source.
Lucas PA; Aubineau-Lanièce I; Lourenço V; Vermesse D; Cutarella D
Med Phys; 2014 Jan; 41(1):011711. PubMed ID: 24387503
[TBL] [Abstract][Full Text] [Related]
38. Thin CaSO4:Dy thermoluminescent dosimeters for calibration of 90Sr+90Y applicators.
Antonio PL; Oliveira ML; Caldas LV
Appl Radiat Isot; 2012 Apr; 70(4):790-3. PubMed ID: 22304964
[TBL] [Abstract][Full Text] [Related]
39. Performance assessment of the BEBIG MultiSource high dose rate brachytherapy treatment unit.
Palmer A; Mzenda B
Phys Med Biol; 2009 Dec; 54(24):7417-34. PubMed ID: 19934487
[TBL] [Abstract][Full Text] [Related]
40. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
